Clinical Trials Browser

Phase 1/2 × Advanced Gastrointestinal Tumors × Clear all

NCT04612712 2022-11-29

A Phase 1/2 Study of Donafenib in Combination With KN046 in Advanced Gastrointestinal Tumors

Phase 1/2 Unknown

Gastrointestinal

Advanced Gastrointestinal Tumors